ML and AI Implementation Insights for Bio/Pharma Manufacturing

Published on: 
BioPharm International, BioPharm International, October 2023, Volume 36, Issue 10
Pages: 24–29

A survey was conducted to examine the adoption of machine learning and artificial intelligence in the bio/pharma manufacturing industry.

This survey conducted by the authors examined factors of Roger’s diffusion of innovation theory related to adopting machine learning (ML) and artificial intelligence (AI) in the bio/pharmaceutical manufacturing industry. The sample included industry leaders and bio/pharmaceutical professionals with experience in regulatory affairs, product development, and commercial operations at FDA-regulated bio/pharmaceutical companies. Participants responded to a survey administered with a direct link for confidentiality. Respondents were asked 44 questions on the adoption challenges of ML and AI practices in bio/pharma manufacturing.

According to the results, creating ML and AI solutions catering to manufacturing segments can quickly generate a customer base. The survey also found that the first areas to be affected by AI are likely to be those related to process efficiency because decision making related to manufacturing efficiency tends to be less regulated compared to quality decision making. In addition, the greatest opportunity for return on investment (ROI) in ML and AI implementation in bio/pharma manufacturing maybe waste reduction, batch yields, and faster batch completion, which are well-aligned with existing lean manufacturing principles. In the current scenario, it is essential to provide training courses for bio/pharma professionals to collaborate in identifying opportunities and developing and implementing ML and AI projects. This will help professionals adapt to the digital revolution and stay ahead in the rapidly changing bio/pharma manufacturing industry.


Peer-reviewed research

Submitted: May 10, 2023
Accepted: Aug. 9, 2023

About the authors

Ajay Babu Pazhayattil, DBA, M.Pharm,, is a pharmaceutical management consultant for cGMP World, and Gyongyi Konyu-Fogel, DBA, D.Ed.,, is a graduate professor of business, at the University of Maryland Global Campus.

Article Details

BioPharm International
Volume 36, No. 10
October 2023
Pages: 24–29


When referring to this article, please cite it as Pazhayattil, A. B.; Konyu-Fogel, G. ML and AI Implementation Insights for Bio/Pharma Manufacturing. BioPharm International2023, 36 (10), 24–29.